Tags » Genentech

Genentech: Beyond The Cycle

Immunotherapy is powerful and complex – for those who want to understand it better, read here:

A new conceptual framework could help guide the future of personalized… 8 more words

Allgemein

How Do You Scale a Company to 15,000 Employees?

Picture this: You’re the co-founder of a promising young biotechnology company in San Francisco. Of the two founders, you’re the geeky one—the brilliant biochemist who developed an idea that the other guy, a venture capitalist, is working to bring to market. 231 more words

Leadership

California Bill Would Halt Practice Of Pharmaceutical Industry Gifts To Doctors

SAN FRANCISCO (CBS SF) — The common practice of doctors accepting gifts from drug manufacturers may soon come to a screeching halt in California following passage of a bill Thursday in the state Senate. 388 more words

News

FDA approves new drug to treat multiple sclerosis Ocrevus (ocrelizumab)

FDA approves new drug to treat multiple sclerosis

03/29/2017

On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). 539 more words

The FDA Just Approved the First Ever Drug to Treat Severe MS

Late Tuesday, the Food and Drug Administration (FDA) approved a groundbreaking multiple sclerosis treatment from Roche/Genentech—the first one ever approved to treat a severe form of MS called primary progressive multiple sclerosis (PPMS). 312 more words

Health

FDA Approves First Drug for Severe Multiple Sclerosis

Federal officials have approved the first drug to treat people with a severe form of multiple sclerosis (MS), a nervous system disease that harms the brain’s ability to communicate with the rest of the body. 168 more words

Book review: Genentech - "The Beginnings of Biotech"

As I currently own a 5% poisiton in  (special situation) Biotech company Actelion, I thought it makes sense trying to learn at least a little bit about Biotech. 435 more words

What We Read